Tag : clears

Latest News

Health Canada Clears Appili Therapeutics for New Phase 3 Clinical Trial to Evaluate Avigan Tablets (Favipiravir) in the Prevention of COVID-19 in Exposed Individuals in the Community

Newsemia
HALIFAX, Nova Scotia–(BUSINESS WIRE)– #Appili–APLI announced the initiation of its Phase 3 PEPCO study to evaluate Avigan® tablets (favipiravir) in the prevention of COVID-19. Source...
Neurology

FDA Clears Smartphone App to Interrupt PTSD-Related Nightmares

Newsemia
The NightWare app uses Apple Watch sensors to monitor heart rate and body movement during sleep and delivers slight vibrations to arouse a patient when...
AI/ML

With lidar and artificial intelligence, road status clears up after a disaster

Newsemia
Consider the days after a hurricane strikes. Trees and debris are blocking roads, bridges are destroyed, and sections of roadway are washed out. Emergency managers...
Neurology

FDA Clears New Neurosurgical Port for Deep Brain Access

Newsemia
The FDA has cleared MindsEye (Minnetronix Medical), the first minimally invasive, expandable and retractable port that allows deep brain access to treat stroke, cancer, and...
Neurology

FDA Clears First Brain Stimulation Device to Help Smokers Quit

Newsemia
The BrainsWay deep TMS system with H4-coil targets addiction-related brain circuits and is indicated as an aid for short-term smoking cessation in adults. FDA Approvals...
Neurology

FDA Clears Rapid Large-Vessel Occlusion Detection Software

Newsemia
The software identifies suspected large-vessel occlusions with a sensitivity of 97% and a specificity of 96%. FDA Approvals Source link...
AI/ML

With lidar and artificial intelligence, road status clears up after a disaster

Newsemia
Consider the days after a hurricane strikes. Trees and debris are blocking roads, bridges are destroyed, and sections of roadway are washed out. Emergency managers...
Latest News

FDA Clears Ozanimod (Zeposia) for MS; COVID-19 Delays Launch

Newsemia
Ozanimod is the first oral, once-daily sphingosine-1-phosphate receptor modulator approved for adults with relapsing forms of multiple sclerosis. Source link...
Latest News

UnitedHealth Group Study Clears Path for Self-Administered COVID-19 Test, Improving Testing Efficiency and Protecting Health Care Workers

Newsemia
MINNETONKA, Minn.–(BUSINESS WIRE)–A UnitedHealth Group study demonstrated that a simple, self-administered test is as effective in identifying COVID-19 infections as the current test. Source link...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy